3rd generation glp-1 Retatrutide is a “GLP-3” therapy, meaning it acts on three hormone receptors — GLP-1, GIP, and glucagon — to influence appetite regulation, blood sugar control, and energy expenditure. By working across these GLP-1-based therapies for diabetes, obesity

If timing feels overwhelming, here's the simplest framework: dose 90-120 minutes before whichever meal you'd most like to eat less of

In Part 2, well discuss strategies for managing and preventing medication-related side effects New to this series

So it was precarious

Typically, they might be administered once or twice a week over a period to achieve desired antioxidant and detoxication benets

Terms as of 2026: For commercially insured patients with Zepbound coverage: as low as $25/month for the first 6 months, then variable

States Where BCBS Has Dropped GLP-1 Coverage The trend to watch in 2026 is BCBS affiliates pulling back on GLP-1 weight loss drug coverage